Loading

BIIB — BIOGEN INC. · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

BIIB

BIOGEN INC.D4515-min delayed · EOD close

220.83▼ −1.64% downas of 2026-09-04mkt cap $32.6B

Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000875045

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

Market cap

$32.6B

P/E

93.9

Net margin

3.4%

ROE

2.3%

Revenue

$10.3B

latest annual

Net income

$348M

latest annual

Shares out

148M

Free cash flow

$2.1B

52-week range

Current: 220.83

▲

Low

135.67

High

224.51

Quality score

45/100

D

Growth16

Business quality47

Financial health55

Valuation60

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.